Low sensitivity of the careHPV™ Assay for detection of Oncogenic Human Papillomavirus in cervical samples from HIV-infected and HIV-uninfected Kenyan women
Authors:
- Titus MTMTitus M
- Ermel AEAErmel A
- Moormann AMAMoormann A
- Cu-Uvin SCSCu-Uvin S
- Orang’o OOOOrang’o O
- Tonui PTPTonui P
- Chelimo KCKChelimo K
- Rosen BRBRosen B
- Itsura PIPItsura P
- Muthoka KMKMuthoka K
- Loehrer PLPLoehrer P
- Ong’eCha JmOJOng’eCha Jm
Open Access
- 30 January 2020
- journal article
- Published by Heighten Science Publications Corporation in International Journal of Clinical Virology
- Vol. 4 (1) , 001-005
Abstract
Background: Human papillomavirus (HPV) infection causes cervical cancer (CC), a common malignancy among Kenyan women. New CC screening methods rely on oncogenic HPV (“high-risk”, or HR-HPV) detection, but most have not been evaluated in swabs from Kenyan women. Methods: HPV typing was performed on 155 cervical swabs from Kenyan women using the Roche Linear Array® (LA) and careHPV™ (careHPV) assays. Detection of 14 oncogenic HPV types in careHPV assay was compared to LA results. Results: Compared to LA, sensitivity and specificity of careHPV assay was 53.0% and 80.9%, respectively. The sensitivity and specificity of careHPV in swabs from women with cervical dysplasia was 74.1% and 65.2%, respectively. The sensitivity and specificity of careHPV in swabs from HIV-infected women was 55.9% and of 96.4%, respectively. Overall agreements of careHPV assay with LA was substantial. Conclusion: The results for careHPV assay are promising for oncogenic HPV detection in Kenyan women. The low sensitivity of careHPV for detection of HR-HPV could limit it’s benefit as a screening tool. Thus, a full clinical validation study is highly desirable before the careHPV assay can be accepted for cervical cancer screening.Keywords
This publication has 17 references indexed in Scilit:
- Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern NigeriaInfectious Agents and Cancer, 2015
- Comparison of Analytical and Clinical Performances of the Digene HC2 HPV DNA Assay and the INNO-LiPA HPV Genotyping Assay for Detecting High-Risk HPV Infection and Cervical Neoplasia Among HIV-Positive African WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
- High-risk HPV nucleic acid detection kit–the careHPV test –a new detection method for screeningScientific Reports, 2014
- Molecular Diagnostics of Human PapillomavirusLaboratory Medicine, 2010
- Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) Positivity in Cervical Cancer Screening of Women in a Peri-Urban Area in Andhra Pradesh, IndiaCancer Epidemiology, Biomarkers & Prevention, 2010
- A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent WomenThe Journal of Infectious Diseases, 2005
- Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic)Canadian Medical Association Journal, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Papillomavirus infections — a major cause of human cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Statistical Methodology: I. Incorporating the Prevalence of Disease into the Sample Size Calculation for Sensitivity and SpecificityAcademic Emergency Medicine, 1996